Looks like the days of easy-FDA approvals are over. Or is it...

First 269 Last

Share
Profile

Follow
Pledge

8,669 Posts.

1455

31/03/25

08:55

Post #: 78474914
Share

Originally posted by Pledge: ↑

The FDA under Marks is Chemist Warehouse in the US.

Cynata should do their trials with WHO.

Cynata is in the process of doing its first P3 ever and it’s not with the FDA. Cynata is one third enrolled for its first ever trial with the FDA - a 60 candidate P2.

SI has completed multiple FDA trials and many of them successfully (multiple P2s successfully) and achieved FDA approval for one.

A Cynata shareholder throwing shade on SI over trials, really doesn’t make a lot of sense. It’s ridiculous actually and reflects poorly on you for trying.

You’re bitter about the outcome. You were wrong.

SI and MSB are world leading pioneers in MSCs. Cynata are not even in the conversation. They are a long way behind.

You have to recognise and deal with it. Or not.

Maybe Cynata is too good for FDA approval. That’s what you are trying to convince yourself of. Really?

Expand

Looks like the days of easy-FDA approvals are over. Or is it that they just got a whole lot easier. 'FDA under Marks' reign - officially over.

Time will tell. Both statements above can't be correct at the same time. I suggest one of them is wrong. At least.

CYP might be given FDA approval without the P2 results? Hang on to your hats (if you can still afford hats)!

CYP Price at posting: 19.0¢ Sentiment: None Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

NUZ

This stock is crafting a cure for Huntington's – and it's making progress

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

RC1

Redcastle teams up with Terra Mining to get revenue flowing at Redcastle Reef, Queen Alexandra projects

ASX Market Close: Index treads water as Energy stocks surge | Monday June 16, 2025

Monday's HotCopper trends: 4DS falls short, $30B bid for Santos | June 16, 2025

First 269 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 16.5¢		Change -0.005(2.94%)		Mkt cap ! $37.28M

Open	High	Low	Value	Volume
16.5¢	17.0¢	16.5¢	$39.66K	238.2K

Buyers (Bids)

No.	Vol.	Price($)
5	277684	16.5¢

Sellers (Offers)

Price($)	Vol.	No.
17.5¢	14285	1

View Market Depth

No.	Vol.	Price($)
5	277684	0.165
6	607381	0.160
3	26451	0.155
3	115000	0.150
2	45937	0.140

Price($)	Vol.	No.
0.175	14285	1
0.180	108494	4
0.185	94565	3
0.190	133868	2
0.195	19300	1

Last trade - 16.10pm 16/06/2025 (20 minute delay)

CYP (ASX) Chart

Looks like the days of easy-FDA approvals are over. Or is it...

This stock is crafting a cure for Huntington's – and it's making progress

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

Redcastle teams up with Terra Mining to get revenue flowing at Redcastle Reef, Queen Alexandra projects

ASX Market Close: Index treads water as Energy stocks surge | Monday June 16, 2025

Monday's HotCopper trends: 4DS falls short, $30B bid for Santos | June 16, 2025

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Looks like the days of easy-FDA approvals are over. Or is it...

Top Stories

This stock is crafting a cure for Huntington's – and it's making progress

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

Redcastle teams up with Terra Mining to get revenue flowing at Redcastle Reef, Queen Alexandra projects

ASX Market Close: Index treads water as Energy stocks surge | Monday June 16, 2025

Monday's HotCopper trends: 4DS falls short, $30B bid for Santos | June 16, 2025

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News